Ulinastatin suppresses inflammatory response in acute lung injury induced by lipopolysacccharide

LIU Hong,AN You-zhong,LI Fang-fang,GUO Yan
DOI: https://doi.org/10.3969/j.issn.1671-6205.2008.04.015
2008-01-01
Abstract:Objective To investigate the possible role of ulinastatin(UTI)in lipopolysacccharide(LPS)-induced acute lung injury(ALI).Methods Thirty male SD rats were randomly divided into three groups,ie.a normal control group,a LPS group and a LPS plus UTI group.The rats were injected with 1 mL of normal saline via caudal vein in the control group,with LPS 5 mg/kg via caudal vein in the LPS group,and with UTI 100000 U/kg shortly after injection with LPS in the LPS plus UTI group.The rats were sacrificed 4 h after the injection.Lung wet/dry weight ratio was measured.IL-18 level in serum and lung tissue was determined by ELISA and the expression of NF-κB in lung tissue was determined by immunohistochemistry.Pathological changes of rats' lung were observed by optical and electron microscope.Results Compared with the control group,IL-18 level in serum and NF-κB expression in lung tissue were significantly higher in the LPS group(P<0.01).The IL-8 level was somewhat elevated in the LPS+UTI group but with no significant difference from that in control group was found(P>0.05).The lung inflammation in the LPS+UTI group was milder than that in the LPS rats.Conclusion UTI can alleviate LPS-induced inflammatory reaction and lung injury in rat model.
What problem does this paper attempt to address?